Mersana Therapeutics, Inc.MRSNNASDAQ
LOADING
|||
Switch Symbol:
Gross Profit Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year gross profit growth rate
Latest
297.58%
↑ 106% above average
Average (38q)
-4703.14%
Historical baseline
Range
High:16545.45%
Low:-207790.91%
Volatility
-4769.9%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | 297.58% |
| Q2 2025 | 0.54% |
| Q1 2025 | -83.17% |
| Q4 2024 | 29.87% |
| Q3 2024 | 449.41% |
| Q2 2024 | -75.20% |
| Q1 2024 | -9.84% |
| Q4 2023 | 41.03% |
| Q3 2023 | -29.61% |
| Q2 2023 | 38.05% |
| Q1 2023 | -48.06% |
| Q4 2022 | 168.77% |
| Q3 2022 | 32.12% |
| Q2 2022 | 121.57% |
| Q1 2022 | 16545.45% |
| Q4 2021 | 0.00% |
| Q3 2021 | 0.00% |
| Q2 2021 | 0.00% |
| Q1 2021 | 100.05% |
| Q4 2020 | -207790.91% |
| Q3 2020 | -98.62% |
| Q2 2020 | 7136.36% |
| Q1 2020 | -73.81% |
| Q4 2019 | 100.33% |
| Q3 2019 | 5.21% |
| Q2 2019 | -152.39% |
| Q1 2019 | 238.99% |
| Q4 2018 | -42.98% |
| Q3 2018 | -53.79% |
| Q2 2018 | 7.83% |
| Q1 2018 | 18.61% |
| Q4 2017 | -119.51% |
| Q3 2017 | 25.43% |
| Q2 2017 | -18.64% |
| Q1 2017 | -284.58% |
| Q4 2016 | 173.40% |
| Q3 2016 | -119.48% |
| Q2 2016 | 47.69% |
| Q1 2016 | 0.00% |